Michael S Wyzga insider trades

Open-market stock purchases and sales by Michael S Wyzga, Unknown at Tvardi Therapeutics, Inc, from SEC Form 4 filings since May 24, 2010.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +79%.

Recent trades

DateStockTradeValue
Jun 9, 2026TVRD Tvardi Therapeutics, IncBought (not open market)—
Feb 26, 2026MREO Mereo BioPharma Group plcBought (not open market)—
Jan 1, 2026XFOR X4 Pharmaceuticals, IncBought (not open market)—

Companies traded

  • TVRD Tvardi Therapeutics, Inc: other filings, last Jun 9, 2026
  • MREO Mereo BioPharma Group plc: other filings, last Feb 26, 2026
  • XFOR X4 Pharmaceuticals, Inc: 1 buy, last Jan 1, 2026
  • IVVD Invivyd, Inc: other filings, last May 23, 2023
  • LOGC LogicBio Therapeutics, Inc: other filings, last Nov 16, 2022
  • ADGI Adagio Therapeutics, Inc: other filings, last Jun 22, 2022
  • EXAS Exact Sciences Corp: 4 sales, last Feb 26, 2021
  • OMED OncoMed Pharmaceuticals Inc: other filings, last Jun 22, 2018
  • AKBA Akebia Therapeutics, Inc: 1 buy, last Jun 14, 2018
  • IDIX Idenix Pharmaceuticals Inc: other filings, last Aug 5, 2014
  • NONE Radius Health, Inc: other filings, last Dec 15, 2011
  • GENZ Genzyme Corp: 1 sale, last Apr 4, 2011

Get free alerts when Michael S Wyzga files a new trade →